Aberrant trafficking of transmembrane proteins in human disease

Trends in Cell Biology

Volumn 13, Issue 12, 2003, Pages 639-647

  Cobbold, Christian ^a   Monaco, Anthony P ^a   Sivaprasadarao, Asipu ^b   Ponnambalam, Sreenivasan ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1 [2 (6 METHYL 2 PYRIDYL)ETHYL] 4 (4 METHYLSULFONYLAMINOBENZOYL)PIPERIDINE; 11 CIS RETINAL; AQUAPORIN 2; DIAZOXIDE; DIMETHYL SULFOXIDE; G PROTEIN COUPLED RECEPTOR; GLYCEROL; GROWTH FACTOR RECEPTOR; ION CHANNEL; LIXIVAPTAN; MEMBRANE PROTEIN; MPB 07; MPB 091; N TERT BUTYL 4 [5' ETHOXY 4 (2 MORPHOLINOETHOXY) 2' OXOSPIRO[CYCLOHEXANE 1,3' INDOLE] 1' SULFONYL] 3 METHOXYBENZAMIDE; OPSIN; SULFONYLUREA RECEPTOR; THAPSIGARGIN; UNCLASSIFIED DRUG; VASOPRESSIN V2 RECEPTOR;

CELL MEMBRANE TRANSPORT; CYSTIC FIBROSIS; DIABETES INSIPIDUS; GOLGI COMPLEX; HUMAN; HYPERINSULINISM; LONG QT SYNDROME; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DEGRADATION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN STABILITY; QUALITY CONTROL; RETINITIS PIGMENTOSA; REVIEW; SIGNAL TRANSDUCTION;

EID: 0242559040     PISSN: 09628924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcb.2003.10.008     Document Type: Review

References (91)

1. Aridor M., Hannan L.A. Traffic jam: a compendium of human diseases that affect intracellular transport processes. Traffic. 1:2000;836-851.
2. Aridor M., Hannan L.A. Traffic jams II: an update of diseases of intracellular transport. Traffic. 3:2002;781-790.
3. Swanton E., Bulleid N.J. Protein folding and translocation across the endoplasmic reticulum membrane. Mol. Membr. Biol. 20:2003;99-104.
4. Rutishauser J., Spiess M. Endoplasmic reticulum storage diseases. Swiss Med. Wkly. 132:2002;211-222.
5. Borel A.C., Simon S.M. Biogenesis of polytopic membrane proteins: membrane segments assemble within translocation channels prior to insertion within the endoplasmic reticulum. Cell. 85:1996;379-389.
6. Mothes W., et al. Molecular mechanisms of membrane protein insertion into the endoplasmic reticulum. Cell. 89:1997;523-533.
7. Ellgaard L., et al. Setting the standards: quality control in the secretory pathway. Science. 286:1999;1882-1888.
8. Bertrand C.A., Frizzell R.A. The role of regulated CFTR trafficking in epithelial secretion. Am. J. Physiol. Cell Physiol. 285:2003;C1-C18.
9. Pind S., et al. Participation of the endoplasmic reticulum chaperone calnexin (p88, IP90) in the biogenesis of the cystic fibrosis transmembrane conductance regulator. J. Biol. Chem. 269:1994;12784-12788.
10. Halaban R., et al. Endoplasmic reticulum retention is a common defect associated with tyrosinase-negative albinism. Proc. Natl. Acad. Sci. U. S. A. 97:2000;5889-5894.
11. Meacham G.C., et al. The Hdj-2/Hsc70 pair facilitates early steps in CFTR biogenesis. EMBO J. 18:1999;1492-1505.
12. Ficker E., et al. Retention in the endoplasmic reticulum as a mechanism of dominant-negative current suppression in human long QT syndrome. J. Mol. Cell. Cardiol. 32:2000;2327-2337.
13. Kupershmidt S., et al. Defective human Ether-a-go-go-related gene trafficking linked to an endoplasmic reticulum retention signal in the C terminus. J. Biol. Chem. 277:2002;27442-27448.
14. Meissner T., et al. Congenital hyperinsulinism: molecular basis of a heterogeneous disease. Hum. Mutat. 13:1999;351-361.
15. Cartier E.A., et al. Defective trafficking and function of KATP channels caused by a sulfonylurea receptor 1 mutation associated with persistent hyperinsulinemic hypoglycemia of infancy. Proc. Natl. Acad. Sci. U. S. A. 98:2001;2882-2887.
16. Partridge C.J., et al. Identification and pharmacological correction of a membrane trafficking defect associated with a mutation in the sulfonylurea receptor causing familial hyperinsulinism. J. Biol. Chem. 276:2001;35947-35952.
17. Harris E.D. Cellular copper transport and metabolism. Annu. Rev. Nutr. 20:2000;291-310.
18. Cobbold C., et al. Novel membrane traffic steps regulate the exocytosis of the Menkes disease ATPase. Hum. Mol. Genet. 11:2002;2855-2866.
19. Standley S., et al. PDZ domain suppression of an ER retention signal in NMDA receptor NR1 splice variants. Neuron. 28:2000;887-898.
20. Margeta-Mitrovic M., et al. A trafficking checkpoint controls GABA(B) receptor heterodimerization. Neuron. 27:2000;97-106.
21. Zerangue N., et al. A new ER trafficking signal regulates the subunit stoichiometry of plasma membrane K(ATP) channels. Neuron. 22:1999;537-548.
22. Girard C., et al. p11, An annexin II subunit, an auxiliary protein associated with the background K+ channel, TASK-1. EMBO J. 21:2002;4439-4448.
23. Trudeau M.C., Zagotta W.N. An intersubunit interaction regulates trafficking of rod cyclic nucleotide-gated channels and is disrupted in an inherited form of blindness. Neuron. 34:2002;197-207.
24. Saliba R.S., et al. The cellular fate of mutant rhodopsin: quality control, degradation, aggresome formation. J. Cell Sci. 115:2002;2907-2918.
25. Meacham G.C., et al. The Hsc70 co-chaperone CHIP targets immature CFTR for proteasomal degradation. Nat. Cell Biol. 3:2001;100-105.
26. Hewitt E.W. The MHC Class I antigen presentation pathway: strategies for viral immune evasion. Immunology. 110:2003;163-169.
27. Cabral C.M., et al. Dissecting glycoprotein quality control in the secretory pathway. Trends Biochem. Sci. 26:2001;619-624.
28. Duden R. ER-to-Golgi transport: COP I and COP II function. Mol. Membr. Biol. 20:2003;197-207.
29. Barlowe C. Signals for COPII-dependent export from the ER: what's the ticket out? Trends Cell Biol. 13:2003;295-300.
30. Sonnichsen B., et al. Sorting by COP I-coated vesicles under interphase and mitotic conditions. J. Cell Biol. 134:1996;1411-1425.
31. Sollner T.H. Regulated exocytosis and SNARE function. Mol. Membr. Biol. 20:2003;209-220.
32. Yoo J.S., et al. Non-conventional trafficking of the cystic fibrosis transmembrane conductance regulator through the early secretory pathway. J. Biol. Chem. 277:2002;11401-11409.
33. Zhang B., et al. Bleeding due to disruption of a cargo-specific ER-to-Golgi transport complex. Nat. Genet. 34:2003;220-225.
34. O'Kelly I., et al. Forward transport. 14-3-3 binding overcomes retention in endoplasmic reticulum by dibasic signals. Cell. 111:2002;577-588.
35. Yuan H., et al. 14-3-3 dimers probe the assembly status of multimeric membrane proteins. Curr. Biol. 13:2003;638-646.
36. Rabouille C., Jokitalo E. Golgi apparatus partitioning during cell division. Mol. Membr. Biol. 20:2003;117-127.
37. Elsner M., et al. Cisternal maturation and vesicle transport: join the band wagon! Mol Membr. Biol. 20:2003;221-229.
38. Ponnambalam S., Baldwin S.A. Constitutive protein secretion from the trans-Golgi network to the plasma membrane. Mol. Membr. Biol. 20:2003;129-139.
39. Marsh B.J., et al. Organellar relationships in the Golgi region of the pancreatic beta cell line, HIT-T15, visualized by high resolution electron tomography. Proc. Natl. Acad. Sci. U. S. A. 98:2001;2399-2406.
40. Steiner H., Haass C. Intramembrane proteolysis by presenilins. Nat. Rev. Mol. Cell Biol. 1:2000;217-224.
41. Munro S. Localization of proteins to the Golgi apparatus. Trends Cell Biol. 8:1998;11-15.
42. Qi M., Byers P.H. Constitutive skipping of alternatively spliced exon 10 in the ATP7A gene abolishes Golgi localization of the menkes protein and produces the occipital horn syndrome. Hum. Mol. Genet. 7:1998;465-469.
43. Francis M.J., et al. A Golgi localization signal identified in the Menkes recombinant protein. Hum. Mol. Genet. 7:1998;1245-1252.
44. Liljedahl M., et al. Protein kinase D regulates the fission of cell surface destined transport carriers from the trans-Golgi network. Cell. 104:2001;409-420.
45. Cohen D., et al. Selective control of basolateral membrane protein polarity by cdc42. Traffic. 2:2001;556-564.
46. Cobbold C., et al. The Menkes disease ATPase (ATP7A) is internalized via a Rac1-regulated, clathrin- and caveolae-independent pathway. Hum. Mol. Genet. 12:2003;1523-1533.
47. Starcevic M., et al. The molecular machinery for the biogenesis of lysosome-related organelles: lessons from Hermansky-Pudlak syndrome. Semin. Cell Dev. Biol. 13:2002;271-278.
48. Devonald M.A., et al. Non-polarized targeting of AE1 causes autosomal dominant distal renal tubular acidosis. Nat. Genet. 33:2003;125-127.
49. Koivisto U.M., et al. A novel cellular phenotype for familial hypercholesterolemia due to a defect in polarized targeting of LDL receptor. Cell. 105:2001;575-585.
50. Koval M., et al. Connexin-46 is retained as monomers in a trans-Golgi compartment of osteoblastic cells. J. Cell Biol. 137:1997;847-857.
51. Slimane T.A., et al. Raft-mediated trafficking of apical resident proteins occurs in both direct and transcytotic pathways in polarized hepatic cells: role of distinct lipid microdomains. Mol. Biol. Cell. 14:2003;611-624.
52. Claas C., et al. Evaluation of prototype transmembrane 4 superfamily protein complexes and their relation to lipid rafts. J. Biol. Chem. 276:2001;7974-7984.
53. Roper K., et al. Retention of prominin in microvilli reveals distinct cholesterol-based lipid micro-domains in the apical plasma membrane. Nat. Cell Biol. 2:2000;582-592.
54. Corbeil D., et al. Prominin: a story of cholesterol, plasma membrane protrusions and human pathology. Traffic. 2:2001;82-91.
55. Scheiffele P., et al. N-glycans as apical sorting signals in epithelial cells. Nature. 378:1995;96-98.
56. Benting J.H., et al. N-Glycans mediate the apical sorting of a GPI-anchored, raft-associated protein in Madin-Darby canine kidney cells. J. Cell Biol. 146:1999;313-320.
57. Owen D.J., Luzio J.P. Structural insights into clathrin-mediated endocytosis. Curr. Opin. Cell Biol. 12:2000;467-474.
58. Sorkin A., von Zastrow M. Signal transduction and endocytosis: close encounters of many kinds. Nat. Rev. Mol. Cell Biol. 3:2002;600-614.
59. Davis C.G., et al. The J.D. mutation in familial hypercholesterolemia: amino acid substitution in cytoplasmic domain impedes internalization of LDL receptors. Cell. 45:1986;15-24.
60. Wu, J.H. et al., (2003) The adaptor protein β-arrestin2 enhances endocytosis of the low-density lipoprotein receptor. J. Biol. Chem., (in press).
61. Tsao P.I., von Zastrow M. Diversity and specificity in the regulated endocytic membrane trafficking of G-protein-coupled receptors. Pharmacol. Ther. 89:2001;139-147.
62. Gage R.M., et al. A transplantable sorting signal that is sufficient to mediate rapid recycling of G protein-coupled receptors. J. Biol. Chem. 276:2001;44712-44720.
63. Lee A., et al. Distribution analysis of nonsynonymous polymorphisms within the G-protein-coupled receptor gene family. Genomics. 81:2003;245-248.
64. Schiaffino M.V., et al. Ocular albinism: evidence for a defect in an intracellular signal transduction system. Nat. Genet. 23:1999;108-112.
65. Atlas D. Functional and physical coupling of voltage-sensitive calcium channels with exocytotic proteins: ramifications for the secretion mechanism. J. Neurochem. 77:2001;972-985.
66. Peters K.W., et al. Role of SNARE proteins in CFTR and ENaC trafficking. Pflugers Arch. 443:2001;S65-S69.
67. Lin J.W., et al. Distinct molecular mechanisms and divergent endocytotic pathways of AMPA receptor internalization. Nat. Neurosci. 3:2000;1282-1290.
68. Connolly C.N., et al. Cell surface stability of γ-aminobutyric acid type A receptors. Dependence on protein kinase C activity and subunit composition. J. Biol. Chem. 274:1999;36565-36572.
69. Nong Y., et al. Glycine binding primes NMDA receptor internalization. Nature. 422:2003;302-327.
70. Hartmann-Petersen R., et al. Transferring substrates to the 26S proteasome. Trends Biochem. Sci. 28:2003;26-31.
71. Glickman M.H., Ciechanover A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol. Rev. 82:2002;373-428.
72. Konstas A.A., et al. Regulation of the epithelial sodium channel by N4WBP5A, a novel Nedd4/Nedd4-2-interacting protein. J. Biol. Chem. 277:2002;29406-29416.
73. Bedford F.K., et al. GABA(A) receptor cell surface number and subunit stability are regulated by the ubiquitin-like protein Plic-1. Nat. Neurosci. 4:2001;908-916.
74. Leitch V., et al. Altered ubiquitination and stability of aquaporin-1 in hypertonic stress. Proc. Natl. Acad. Sci. U. S. A. 98:2001;2894-2898.
75. Wojcikiewicz R.J., et al. Ubiquitination and proteasomal degradation of endogenous and exogenous inositol 1,4,5-trisphosphate receptors in alpha T3-1 anterior pituitary cells. J. Biol. Chem. 278:2003;940-947.
76. Schwake M., et al. An internalization signal in ClC-5, an endosomal Cl-channel mutated in dent's disease. J. Biol. Chem. 276:2001;12049-12054.
77. Schubert U., et al. CD4 glycoprotein degradation induced by human immunodeficiency virus type 1 Vpu protein requires the function of proteasomes and the ubiquitin-conjugating pathway. J. Virol. 72:1998;2280-2288.
78. Haglund K., et al. Multiple monoubiquitination of RTKs is sufficient for their endocytosis and degradation. Nat. Cell Biol. 5:2003;461-466.
79. Morello J.P., et al. Pharmacological chaperones: a new twist on receptor folding. Trends Pharmacol. Sci. 21:2000;466-469.
80. Brown C.R., et al. Chemical chaperones correct the mutant phenotype of the D F508 cystic fibrosis transmembrane conductance regulator protein. Cell Stress Chaperones. 1:1996;117-125.
81. Dormer R.L., et al. Correction of ΔF508-CFTR activity with benzo(c)quinolizinium compounds through facilitation of its processing in cystic fibrosis airway cells. J. Cell Sci. 114:2001;4073-4081.
82. Stratford F.L., et al. Benzo(c)quinolizinium drugs inhibit degradation of ΔF508-CFTR cytoplasmic domain. Biochem. Biophys. Res. Commun. 300:2003;524-530.
83. Tamarappoo B.K., Verkman A.S. Defective aquaporin-2 trafficking in nephrogenic diabetes insipidus and correction by chemical chaperones. J. Clin. Invest. 101:1998;2257-2267.
84. Morello J.P., et al. Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants. J. Clin. Invest. 105:2000;887-895.
85. Egan M.E., et al. Calcium-pump inhibitors induce functional surface expression of ΔF508-CFTR protein in cystic fibrosis epithelial cells. Nat. Med. 8:2002;485-492.
86. Zhou Z., et al. Correction of defective protein trafficking of a mutant HERG potassium channel in human long QT syndrome. Pharmacological and temperature effects. J. Biol. Chem. 274:1999;31123-31126.
87. Noorwez S.M., et al. Pharmacological chaperone-mediated in vivo folding and stabilization of the P23H-opsin mutant associated with autosomal dominant retinitis pigmentosa. J. Biol. Chem. 278:2003;14442-14450.
88. Zeitlin P.L., et al. Evidence of CFTR function in cystic fibrosis after systemic administration of 4-phenylbutyrate. Mol. Ther. 6:2002;119-126.
89. Schwartz J.J., Zhang S. Peptide-mediated cellular delivery. Curr. Opin. Mol. Ther. 2:2000;162-167.
90. Schneider P., et al. A review of drug-induced lysosomal disorders of the liver in man and laboratory animals. Microsc. Res. Tech. 36:1997;253-275.
91. Kisselev A.F., Goldberg A.L. Proteasome inhibitors: from research tools to drug candidates. Chem. Biol. 8:2001;739-758.